Abituzumab Combined with Cetuximab Plus Irinotecan Versus Cetuximab Plus Irinotecan Alone for Patients with KRAS Wild-Type Metastatic Colorectal Cancer: the Randomised Phase I/II POSEIDON Trial.
Annals of Oncology（2014）
Key words
abituzumab,colorectal cancer,integrin,biomarker,monoclonal antibody,phase I/II
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined